The Flinn Foundation has announced its 2024 Bioscience Entrepreneurship Program participants:

Six Arizona startups driving biosciences forward in 2024

Program Eligibility

To be eligible for the program, an entity must be an Arizona-based bioscience company engaged in the commercialization of bioscience research and biotechnology and/or the sale of products in the areas of:

  • Medical devices and equipment;
  • Drugs, pharmaceuticals and diagnostics;
  • Agricultural feedstock and chemicals;
  • Research, testing and medical labs;
  • Bioscience-related distribution.

The company must be incorporated as an S-Corp, LLC, or C-Corp, and based in Arizona and in pre- or early-revenue stage. Research-only projects do not qualify.

Application Requirements

The Flinn Foundation Bioscience Entrepreneurship Program provides $30,000 in non-dilutive funding plus support and connections.

The application consists of a basic application form and three attachments: a two-page executive summary, a 15-slide pitch deck, and one letter of recommendation.  The executive summary must address the company’s business model, financing, execution, market and a description of the innovative product or service.

After interviews with industry and scientific experts chosen by the Flinn Foundation, up to six startups are competitively selected for the program.

Stay tuned for details or contact us about future application opportunities.

Learn more:
Six Arizona startups driving biosciences forward in 2024
Program benefits and background
Meet the program participants from 2014 to today


If you have any questions about the program or application process, please contact Mary O’Reilly, Ph.D., Flinn Foundation Vice President, Bioscience Research Programs.

Diversity drives innovation. While diversity is often used in reference to race, ethnicity, and gender, we understand it to also include diversity in one’s background, life experiences, skill set, and self-identification. We encourage all to apply.